News Sentiment

AHG sentiment intelligence

Akso Health Group ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 38 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Distribution Read-through group
Latest close 1.52 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 38

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +13.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

HSIC Q1 2026 Earnings: EPS Beats Estimates by 6.3%, Stock Edges Higher - Financial Health Score

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 13.4% over four weeks
Fair value 17.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 24
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 38
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 7
TradingKey 7
dars.gov.et 4
Simply Wall Street 4
Stock Titan 4
MarketBeat 3
simplywall.st 2
Bölüm Sonu Canavarı 1

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 9
Analyst action 3
Balance sheet 2
Deals and strategy 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 38
TradingView Direct company coverage

Enterprise value to EBITDA forward of Akso Health Group – NASDAQ:AHG

This article displays financial information for Akso Health Group (NASDAQ: AHG), specifically its enterprise value to EBITDA forward. The content is presented within the TradingView platform, noting that the market is closed, and provides no trade data for the company. It serves

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 12:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Akso Health Group Sponsored ADR – SWB:8HX

This article provides the enterprise value to EBITDA forward for Akso Health Group Sponsored ADR (SWB:8HX) on the Stuttgart Stock Exchange. The data indicates that the market was closed with no trades at the time of publication. It also highlights the various financial services a

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 14:16
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Akso Health Group – NASDAQ:AHG

This article provides financial information for Akso Health Group (NASDAQ: AHG), specifically focusing on its enterprise value to revenue forward. It notes that the market for AHG stock was closed at the time of publication, with no trades reported. The information is presented w

Tone
Neutral 50/100
Event
Earnings
Published
04 Jul 2026 14:11
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Akso Health Group – NASDAQ:AHG

This article provides financial data for Akso Health Group (NASDAQ: AHG), specifically focusing on its forward price-to-earnings ratio. It indicates the stock market for AHG is currently closed with no trades. The content is presented by TradingView, a financial platform offering

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 09:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Akso Health Group – NASDAQ:AHG

This article displays the "Price to sales forward" financial metric for Akso Health Group (NASDAQ: AHG). The content primarily points to a specific financial data element within the TradingView platform, noting that the market was closed at the time of the data display.

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 06:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of Akso Health Group – NASDAQ:AHG

The article focuses on the "Price to book forward" financial metric for Akso Health Group (NASDAQ: AHG). It categorizes the company within the retail trade and internet retail sectors on the Nasdaq Stock Market. The content provided is primarily metadata and navigational informat

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 19:40
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Akso Health Group Sponsored ADR – LS:A2QLR3

The article displays financial data for Akso Health Group Sponsored ADR (LS:A2QLR3), specifically its price-to-earnings forward ratio. It seems to be a snapshot from a financial trading platform like TradingView, showing the absence of current trades and market status.

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 04:11
Source
TradingView
TradingKey Direct company coverage

Akso Health Group (AHG) Financial Health: Profitability & Balance Sheet Analysis

Akso Health Group (AHG) has a weak financial status and low operating efficiency, ranking 473 out of 488 in its industry with a financial score of 5.22. Despite this, the company reported a significant year-over-year revenue increase of 676.00% to 6.93M and an 83.03% increase in

Tone
Neutral 50/100
Event
Earnings
Published
23 Jun 2026 06:11
Source
TradingKey
TradingKey Direct company coverage

Akso Health Group (AHG) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Akso Health Group's (AHG) dividend history and stock split events. It indicates that AHG has not distributed any dividends over the past five years. The company did undergo a 3-for-1 merger type stock split on August 10, 2020.

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Jun 2026 20:09
Source
TradingKey
Simply Wall Street Direct company coverage

Akso Health Group (AHG) Stock Looks Expensive Despite Stronger Quarterly Revenue

Akso Health Group (AHG) recently reported increased quarterly revenue and net profit, but its stock appears expensive with a Price-to-Book ratio of 5.8x compared to the US Healthcare sector's 2.5x. Despite the improved financials, the share price has declined significantly, refle

Tone
Negative 37/100
Event
Earnings
Published
19 Jun 2026 02:14
Source
Simply Wall Street
TradingKey Direct company coverage

Akso Health Group (AHG) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Akso Health Group (AHG), outlining major shareholders and institutional holdings. It shows that "Other" shareholders hold 99.99% of the company, with Renaissance Technologies LLC holding a minor 0.01%. The article also provides a

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 15:14
Source
TradingKey
TradingKey Direct company coverage

Akso Health Group (AHG) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Akso Health Group (AHG), noting its current price momentum score of 6.39 and positioning it for range-bound swing trading between resistance at 1.57 and support at 0.99. It details various technical indicators like MACD, RSI, and movi

Tone
Negative 18/100
Event
Market update
Published
18 Jun 2026 08:09
Source
TradingKey
TradingKey Direct company coverage

Akso Health Group (AHG) Institutional Confidence

Akso Health Group (AHG) has an institutional shareholding score of 3.00, placing it 284th out of 489 in the Software & IT Services industry. The institutional shareholding proportion is 0.02%, which is a 48.17% decrease quarter-over-quarter. James Simons is the largest institutio

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 02:09
Source
TradingKey
TradingKey Direct company coverage

Akso Health Group (AHG) Valuation: PE, PB & Fair Value Analysis

Akso Health Group (AHG) has a current valuation score of 7.23, ranking 368 out of 489 in the Software & IT Services industry. Its P/E ratio is -2.60, which is significantly below its recent high and above its recent low. However, relevant data for P/B, P/S, and P/CF ratios have n

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 02:09
Source
TradingKey
Simply Wall Street Direct company coverage

What Does Akso Health (AHG)'s Auditor Switch Reveal About Its Governance And Transparency Priorities?

Akso Health Group recently switched its independent auditor from Onestop Assurance PAC to CHI-LLTC, effective May 12, 2026. This change is significant given the company's history of small revenue, heavy losses, and ongoing "going concern" warnings. The auditor switch adds another

Tone
Negative 38/100
Event
Balance sheet
Published
24 May 2026 15:35
Source
Simply Wall Street
Simply Wall Street Direct company coverage

Akso Health Group (AHG) Valuation Check After Auditor Change To CHI LLTC

Akso Health Group (AHG) recently changed its independent auditor, dismissing Onestop Assurance PAC and appointing CHI-LLTC, a move that could influence investor perception. Despite a stock price decline of 22.73% in the past month, the company's Price-to-Book ratio of 6.6x is con

Tone
Negative 41/100
Event
Market update
Published
23 May 2026 11:39
Source
Simply Wall Street
The Globe and Mail Direct company coverage

Akso Health Group Switches Independent Auditor to CHI-LLTC

Akso Health Group (AHG) has announced a change in its independent auditor, replacing Onestop Assurance PAC with CHI-LLTC, effective May 12, 2026. This transition follows two fiscal years without adverse opinions or disagreements from the previous auditor, indicating an internal d

Tone
Negative 19/100
Event
Market update
Published
15 May 2026 01:39
Source
The Globe and Mail
Simply Wall Street Direct company coverage

Is Akso Health Group's (AHG) Early BCI Bet Quietly Redefining Its Long-Term Innovation Narrative?

Akso Health Group (AHG) announced an early-stage Brain-Computer Interface (BCI) research and development program, focusing on high-resolution neural sensing and AI decoding. While this BCI initiative could reshape its long-term investment narrative, the company still faces immedi

Tone
Neutral 50/100
Event
Market update
Published
07 May 2026 10:10
Source
Simply Wall Street
MarketBeat Direct company coverage

Akso Health Group (NASDAQ:AHG) Sees Strong Trading Volume - Should You Buy?

Akso Health Group (NASDAQ:AHG) experienced strong trading volume, with shares increasing 91% to 161,604, closing at $2.2780. Despite trading above its 50-day and 200-day moving averages, the company holds a "Sell" consensus rating from analysts, including a "sell (d-)" from Weiss

Tone
Negative 29/100
Event
Analyst action
Published
29 Apr 2026 06:40
Source
MarketBeat
Vietnam Investment Review - VIR Direct company coverage

AHG launches brain-computer interface research program

Akso Health Group (NASDAQ: AHG) has initiated a new proprietary Brain-Computer Interface (BCI) technology research and development program. The company aims to develop and commercialize BCI technology, focusing on ultra-high-resolution neural sensing, AI neural decoding, and next

Tone
Positive 72/100
Event
Market update
Published
28 Apr 2026 10:34
Source
Vietnam Investment Review - VIR
The Manila Times Direct company coverage

AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology

Akso Health Group (NASDAQ: AHG) has initiated a proprietary Brain-Computer Interface (BCI) technology research and development program, aiming to become a leader in neurotechnology. The company is developing innovations in neural sensing, AI neural decoding, and interface design,

Tone
Positive 75/100
Event
Market update
Published
28 Apr 2026 06:09
Source
The Manila Times
www.marketscreener.com Direct company coverage

Akso Health Group Announces Initiation of Proprietary Brain-Computer Interface Technology Research and Development Program

Akso Health Group has announced the initiation of its proprietary Brain-Computer Interface (BCI) technology research and development program. The company aims to develop and commercialize BCI technology, focusing on innovations in neural sensing, real-time AI neural decoding, and

Tone
Positive 67/100
Event
Market update
Published
28 Apr 2026 06:09
Source
www.marketscreener.com